Investor Relations

Press Release

April 8, 2022

Amphastar Receives FDA Approval for Ganirelix Acetate Injection

More
April 6, 2022

Amphastar Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference

More
March 10, 2022

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2021

More
March 3, 2022

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 10th, 2022

More
December 29, 2021

Amphastar Receives FDA Tentative Approval for Vasopressin

More
November 22, 2021

Amphastar Pharmaceuticals to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

More
November 11, 2021

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference

More
November 8, 2021

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2021

More
October 28, 2021

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8th, 2021

More
September 2, 2021

Amphastar Pharmaceuticals to Present at the Wells Fargo 2021 Virtual Healthcare Conference

More
Youtube